Healthcare provider profile · identity verified

Alyn Kelley

Internal Medicine · SACRAMENTO, CA · NPI 1962716035

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	607	209
Levothyroxine Sodium	Levothyroxine Sodium	357	114
Amlodipine Besylate	Amlodipine Besylate	336	125
Losartan Potassium	Losartan Potassium	289	95
Lisinopril	Lisinopril	251	94
Albuterol Sulfate Hfa	Albuterol Sulfate	162	74
Hydrochlorothiazide	Hydrochlorothiazide	155	55
Trazodone Hcl	Trazodone Hcl	154	53
Atenolol	Atenolol	151	51
Famotidine	Famotidine	136	48
Metoprolol Tartrate	Metoprolol Tartrate	133	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	28
Furosemide	Furosemide	112	44
Metformin Hcl	Metformin Hcl	99	36
Pantoprazole Sodium	Pantoprazole Sodium	95	38
Ibuprofen	Ibuprofen	91	36
Fluticasone Propionate	Fluticasone Propionate	90	27
Omeprazole	Omeprazole	89	37
Simvastatin	Simvastatin	87	29
Gabapentin	Gabapentin	79	31
Metformin Hcl Er	Metformin Hcl	78	31
Rosuvastatin Calcium	Rosuvastatin Calcium	74	27
Sertraline Hcl	Sertraline Hcl	71	25
Alendronate Sodium	Alendronate Sodium	61	27
Breyna	Budesonide/Formoterol Fumarate	60	19
Metoprolol Succinate	Metoprolol Succinate	60	24
Lovastatin	Lovastatin	59	18
Pradaxa	Dabigatran Etexilate Mesylate	57	23
Citalopram Hbr	Citalopram Hydrobromide	56	20
Potassium Chloride	Potassium Chloride	56	22
Wixela Inhub	Fluticasone Propion/Salmeterol	55	15
Tamsulosin Hcl	Tamsulosin Hcl	54	24
Fluoxetine Hcl	Fluoxetine Hcl	52	23
Propranolol Hcl	Propranolol Hcl	50	18
Duloxetine Hcl	Duloxetine Hcl	49	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	19
Acyclovir	Acyclovir	48	22
Pravastatin Sodium	Pravastatin Sodium	48	16
Glipizide	Glipizide	47	20
Meloxicam	Meloxicam	47	14
Lorazepam	Lorazepam	46	17
Prednisone	Prednisone	44	29
Mirtazapine	Mirtazapine	43	19
Tramadol Hcl	Tramadol Hcl	43	13
Ondansetron Odt	Ondansetron	42	14
Spironolactone	Spironolactone	42	16
Bupropion Xl	Bupropion Hcl	41	17
Ropinirole Hcl	Ropinirole Hcl	41	12
Warfarin Sodium	Warfarin Sodium	41	15
Baclofen	Baclofen	39	11
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Carvedilol	Carvedilol	37	18
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Alvesco	Ciclesonide	36	13
Allopurinol	Allopurinol	35	18
Escitalopram Oxalate	Escitalopram Oxalate	33	14
Hydralazine Hcl	Hydralazine Hcl	33	12
Xarelto	Rivaroxaban	33	11
Eliquis	Apixaban	32	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	32	13
Clobetasol Propionate	Clobetasol Propionate	31	19
Clopidogrel	Clopidogrel Bisulfate	31	14
Montelukast Sodium	Montelukast Sodium	31	13
Synthroid	Levothyroxine Sodium	31	suppressed
Terazosin Hcl	Terazosin Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	29	12
Estradiol	Estradiol	29	15
Metronidazole	Metronidazole	28	15
Triamcinolone Acetonide	Triamcinolone Acetonide	28	18
Ozempic	Semaglutide	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	11
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Trospium Chloride	Trospium Chloride	21	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Humulin N Kwikpen	Insulin Nph Human Isophane	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Topiramate	Topiramate	18	11
Cefadroxil	Cefadroxil	17	17
Doxycycline Monohydrate	Doxycycline Monohydrate	17	13
Humulin R	Insulin Regular, Human	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Epinephrine	Epinephrine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Clonidine	Clonidine	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Fluocinonide	Fluocinonide	12	suppressed
Fluorouracil	Fluorouracil	12	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	11	11
Benazepril Hcl	Benazepril Hcl	11	suppressed
Dihydroergotamine Mesylate	Dihydroergotamine Mesylate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error